New pill aims to cut blood transfusions for blood disorder patients
Disease control
Completed
This study tested an oral medication called etavopivat in people with sickle cell disease or thalassemia. The main goals were to see if the drug was safe and if it could help patients need fewer blood transfusions or have higher hemoglobin levels. The trial included 53 participan…
Phase: PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC